Microbio Co., Ltd. (TPEX:4128)

Market Cap	10.88B
Revenue (ttm)	1.86B
Net Income (ttm)	-1.03B
Shares Out	588.17M
EPS (ttm)	-1.76
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	779,721
Average Volume	1,414,113
Open	18.35
Previous Close	18.35
Day's Range	18.30 - 18.70
52-Week Range	18.20 - 35.65
Beta	0.55
RSI	34.94
Earnings Date	Mar 10, 2026

About Microbio

Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. It also involved in the trading of organic foods; sale of beverages; provision of technology development, transfer, and consultation services; and publishing of magazine, as well as offers business consulting services. Mic...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2000
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4128

Financial Performance

In 2024, Microbio's revenue was 1.72 billion, an increase of 8.26% compared to the previous year's 1.59 billion. Losses were -1.10 billion, -6.70% less than in 2023.